ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
出版年份 2014 全文链接
标题
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 29, Issue 4, Pages 508-517
出版商
Wiley
发表日期
2014-02-12
DOI
10.1002/mds.25817
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias: Studies with parkinsonian nicotinic receptor knockout mice
- (2013) Maryka Quik et al. BIOCHEMICAL PHARMACOLOGY
- Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease
- (2013) Maryka Quik et al. MOVEMENT DISORDERS
- TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque
- (2013) Tom H. Johnston et al. NEUROPHARMACOLOGY
- α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats
- (2013) Maryka Quik et al. NEUROPHARMACOLOGY
- Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease
- (2012) Susan Duty CNS DRUGS
- Emerging therapies for Parkinsonʼs disease
- (2012) Werner Poewe et al. CURRENT OPINION IN NEUROLOGY
- Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: Correlation with desensitization of α4β2* receptors
- (2012) Jiahui Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- New pharmacological avenues for the treatment ofl-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors
- (2012) Fabio Blandini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder
- (2012) Earle E. Bain et al. JOURNAL OF CLINICAL PSYCHIATRY
- Nicotine as a potential neuroprotective agent for Parkinson's disease
- (2012) Maryka Quik et al. MOVEMENT DISORDERS
- Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
- (2012) Maryka Quik et al. NEUROBIOLOGY OF DISEASE
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD
- (2012) Earle E Bain et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain
- (2012) Michael C. Rowbotham et al. PAIN
- Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+
- (2011) Damien Toulorge et al. FASEB JOURNAL
- Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
- (2011) Mahmoud M. Iravani et al. JOURNAL OF NEURAL TRANSMISSION
- Nicotine Reduces L-DOPA-Induced Dyskinesias by Acting at 2* Nicotinic Receptors
- (2011) L. Z. Huang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
- (2011) Luping Z. Huang et al. NEUROPHARMACOLOGY
- Nicotine Alters Limbic Function in Adolescent Rat by a 5-HT1A Receptor Mechanism
- (2011) Jasmin M Dao et al. NEUROPSYCHOPHARMACOLOGY
- Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia
- (2011) O.A. Timofeeva et al. NEUROSCIENCE
- Striatal plasticity in Parkinson's disease and L-DOPA induced dyskinesia
- (2011) M.M. Iravani et al. PARKINSONISM & RELATED DISORDERS
- 6 2* and 4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
- (2011) M. Quik et al. PHARMACOLOGICAL REVIEWS
- Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
- (2011) Véronique Sgambato-Faure et al. PROGRESS IN NEUROBIOLOGY
- Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
- (2011) George Apostol et al. PSYCHOPHARMACOLOGY
- Nicotinic Receptor-Mediated Reduction in L-DOPA-Induced Dyskinesias May Occur via Desensitization
- (2010) T. Bordia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
- (2010) Alexxai V. Kravitz et al. NATURE
- Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system
- (2010) Fernando Berrendero et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Differential effects of serotonin (5-HT)2receptor-targeting ligands on locomotor responses to nicotine-repeated treatment
- (2010) Magdalena Zaniewska et al. SYNAPSE
- Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination
- (2009) David J. Anderson et al. BIOCHEMICAL PHARMACOLOGY
- Selectivity of ABT-089 for α4β2* and α6β2* nicotinic acetylcholine receptors in brain
- (2009) Michael J. Marks et al. BIOCHEMICAL PHARMACOLOGY
- Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
- (2009) Shun Shimohama BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Serotonin and Parkinson's disease: On movement, mood, and madness
- (2009) Susan H. Fox et al. MOVEMENT DISORDERS
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
- (2009) Edson X. Albuquerque et al. PHYSIOLOGICAL REVIEWS
- Interactions of serotonin (5-HT)2receptor-targeting ligands and nicotine: Locomotor activity studies in rats
- (2009) Magdalena Zaniewska et al. SYNAPSE
- Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
- (2008) Edward D. Levin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Parkinson's disease: Levodopa-induced dyskinesia and signal transduction
- (2008) Emanuela Santini et al. FEBS Journal
- Diversity of vertebrate nicotinic acetylcholine receptors
- (2008) Neil S. Millar et al. NEUROPHARMACOLOGY
- Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents
- (2008) Roberta J. Ward et al. PROGRESS IN NEUROBIOLOGY
- Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
- (2007) Marina et al. Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now